pfizer News

Kolkata, India, February 17, 2012: TCG Lifesciences Limited (“TCGLS”) announced the nomination of a pre-clinical development candidate (“Candidate”) under a R&D collaboration entered into in 2009 with Pfizer Inc. (“Pfizer”).

This conference is part of the Molecular Med TRI-CON 2012 event on February 21-23, 2012 at the Moscone North Convention Center in San Francisco, CA. Advance registration discounts ends on January 13.

Top Healthcare, Biotech and Pharmaceutical Leaders to Meet with Investors in Search of Breakthrough Healthcare Solutions at 'The Global Leaders Healthcare Forum' on January 10

Amarin’s CMO to lead line-up of thought leaders at Cambridge Healthtech Institute’s executive and scientific forum.

Pfizer’s single platform for communicating with all employees help create the ‘One Pfizer’ voice

CHI’s Oncology Clinical Trials conference will highlight three Xalkori case studies by Pfizers’ Hakan Sakul, Ph.D., Keith Wilner, Ph.D., and Erling Thor Donnelly, Ph.D., R.A.C. This conference is part of the Molecular Medicine Tri-Conference.

International senior biopharma professionals gather in London to deconstruct deal trends and get the low-down and insider knowledge of successful partnering deals at this leading European bio-partnering event

Two thought-leaders and experts on phase II clinical trials will be the keynote speakers at the CHI’s Accelerating Proof of Concept: Clinical Success Driven by Science & Strategy, set for October 3-5 at the Crowne Plaza Hotel in Philadelphia, PA.

Kolkata, India, February 17, 2012: TCG Lifesciences Limited (“TCGLS”) announced the nomination of a pre-clinical development candidate (“Candidate”) under a R&D collaboration entered into in 2009 with Pfizer Inc. (“Pfizer”).

Health Insurance & Availability should be the focus & not the Govt’s Draft Policy. Canada & Philippines growth is due to non-Price Control.

This conference is part of the Molecular Med TRI-CON 2012 event on February 21-23, 2012 at the Moscone North Convention Center in San Francisco, CA. Advance registration discounts ends on January 13.

Top Healthcare, Biotech and Pharmaceutical Leaders to Meet with Investors in Search of Breakthrough Healthcare Solutions at 'The Global Leaders Healthcare Forum' on January 10

Amarin’s CMO to lead line-up of thought leaders at Cambridge Healthtech Institute’s executive and scientific forum.

Reimbursement Intelligence, a market-research firm helping biopharma, medical device and diagnostic firms succeed in managed markets, today announced how payers predict the impact of Pfizer’s radical strategy to stay in favor of consumers.

Pfizer chose Enerit ISO 50001 software to implement its energy management program, and was certified to the standard in four months, a record time.

Pfizer’s single platform for communicating with all employees help create the ‘One Pfizer’ voice

CHI’s Oncology Clinical Trials conference will highlight three Xalkori case studies by Pfizers’ Hakan Sakul, Ph.D., Keith Wilner, Ph.D., and Erling Thor Donnelly, Ph.D., R.A.C. This conference is part of the Molecular Medicine Tri-Conference.

Smoking, High Blood Pressure and high cholesterol are the main causes of death in developed countries

With billions of dollars at stake, Pfizer is doing its every bit to save Lipitor from a complete free-fall resulting from its patent expiry later this month.

Symptoms in most of the people affected by the disease appear for the first time after the age of 60. One out of every eight Americans over the age of 60 has Alzheimer.

November 1, join Brian Johnson, Pfizer Senior Director of Supply Chain Security, and expert consultant Russ Somma, in a discussion of best practices for ensuring end-to-end supply chain security in the pharmaceutical industry.

International senior biopharma professionals gather in London to deconstruct deal trends and get the low-down and insider knowledge of successful partnering deals at this leading European bio-partnering event

Insiderslab.com has issued insider trading reports and Equity Research for the following companies: Pfizer (NYSE:PFE), Exxon (NYSE:XOM), EMC (NYSE:EMC), Xilinx (NASDAQ:XLNX), Vertex (NASDAQ:VRTX) & Zions (NASDAQ:ZION).

Insiderslab.com has issued insider trading reports and Equity Research for the following companies: Pfizer (NYSE:PFE), Urban Outfitters (NASDAQ:URBN), General Motors (NYSE:GM), Regions Financial (NYSE:RF), SandRidge (NYSE:SD) & Symantec (NASDAQ:SYMC)

Two thought-leaders and experts on phase II clinical trials will be the keynote speakers at the CHI’s Accelerating Proof of Concept: Clinical Success Driven by Science & Strategy, set for October 3-5 at the Crowne Plaza Hotel in Philadelphia, PA.

Recently published research from Business Monitor International, "Australia Pharmaceuticals & Healthcare Report Q3 2011", is now available at Fast Market Research

Fast Market Research recommends "Dementia Therapeutics - Pipeline Assessment and Market Forecasts to 2017" from GlobalData, now available

Critical Stock Alerts for Cisco (CSCO), Pfizer (PFE), QUALCOMM (QCOM), Dell (DELL), El Paso (EP), & Halliburton (HAL)

This June 9 program provides an inside look at how Pfizer is applying Lean principles to eliminate waste and improve workload volatility in the QA/QC lab.

Recently published research from Datamonitor, "Global Top 10 Pharmaceutical - Industry, Financial and SWOT Analysis", is now available at Fast Market Research

Comprising more than 60% of all therapeutic targets, G-protein coupled receptor and kinase targets are arguably the most exciting proteins in pharmacology today. Find out more by attending this key event

New Pharmaceuticals research report from Datamonitor is now available from Fast Market Research

As the number of mAbs reaching market has increased, the market for global antibody market surged to US$ 39.6 Billion in 2009, RNCOS acknowledged.

Fast Market Research recommends "Australia Pharmaceuticals & Healthcare Report Q2 2011" from Business Monitor International, now available

Recently published research from Business Monitor International, "Nigeria Pharmaceuticals & Healthcare Report Q2 2011", is now available at Fast Market Research

Critical Stock Alerts: Insider Trade for Microsoft (MSFT), Exxon Mobil (XOM), Pfizer (PFE), Clorox (CLX), Genworth (GNW), & Dell (DELL)

New Pharmaceuticals market report from GlobalData: "Macular Edema Therapeutics - Pipeline Assessment and Market Forecasts to 2017"

New Healthcare market report from Business Monitor International: "Germany Pharmaceuticals & Healthcare Report Q1 2011"

Managing Partner and Co-Founder of Face The Music, Paul Kwiecinski announces their newly released 2nd music CD, Your Work is Your Song, which features Marshall Goldsmith.

Recently published research from Business Monitor International, "Egypt Pharmaceuticals Competitive Intelligence Report Q4 2010", is now available at Fast Market Research

New Healthcare market report from Business Monitor International: "Greece Pharmaceuticals Competitive Intelligence Report Q4 2010"

New Pharmaceuticals market report from GlobalData: "Neutropenia - Pipeline Assessment and Market Forecasts to 2017"

Insider Trade Reports for Pfizer (PFE), Hartford Financial Services (HIG), Gilead (GILD), Motorola (MOT), & SanDisk (SNDK); Issued by Insiderslab.com

The AML Therapeutics Market is Forecast to Show Increased Growth until 2017

New Pharmaceuticals research report from Datamonitor is now available from Fast Market Research

Al via anche in Italia Back in Play, l’innovativa campagna europea di sensibilizzazione sulla Spondilite Anchilosante: una malattia infiammatoria cronica dolorosa che colpisce principalmente la colonna vertebrale.

PennyToBuck Stock Updates On NWTT, PFE, MAR For Tuesday September 7th, 2010.

New Healthcare research report from Business Monitor International is now available from Fast Market Research

This Week in Pharma, host Jim Joyce interviews recent CEO of Javelin Pharmaceuticals, Martin Driscoll about the recent merger of Javelin Pharmaceuticals with Hospira.

MRK reported that two pivotal Phase III registration studies for boceprevir, its investigational oral hepatitis C protease inhibitor.

Eisai Inc. and Pfizer Inc (NYSE:PFE) announced that the U.S. Food and Drug Administration (FDA) approved a new once-daily, higher-dose Aricept (donepezil HCl) 23 mg tablet for the treatment of moderate-to-severe Alzheimer’s disease (AD).

PWRM is a leader in bio-medical research and the commercialization of neurodegenerative disease and cancer biomarkers, pathways, and mechanisms of diseases through the development of diagnostic tests and drug targets.

PWRM is a leading edge biotechnology company engaged in the early detection, monitoring, and targeting of

Pfizer Inc. pulling a decade-old leukemia medicine off the U.S. market

Power 3 Medical's - (OTC BB: PWRM.OB) research platform is centered on the study of proteomics, the science of protein interactions within living cells. With a 50+ years of proteomic experience, the Company has identified 334 protein biomarkers.

Fast Market Research recommends "The South Korean Pharmaceutical Market Outlook to 2014: Healthcare regulation and reforms, disease burden and market dynamics" from Business Insights, now available

AROG Pharmaceuticals LLC announced today that it has entered into an exclusive agreement with Pfizer Inc to acquire the worldwide rights to CP-868596 (ARO-002, plarotinib), a small molecule inhibitor of PDGFr (Platelet Derived Growth Factor receptor)

Lawsuit on behalf of investors in Pfizer Inc. (Public, NYSE:PFE) over alleged securities laws violations by Pfizer – Deadline: July 09, 2010 – Contact the Shareholders Foundation, Inc..